FIELD: organic chemistry, chemical technology, medicine, biochemistry, pharmacy.
SUBSTANCE: invention relates to novel 2-(2,6-dichlorophenyl)diarylimidazoles of the general formula (I): 
possessing inhibitory effect on activity of protein-tyrosine kinase and first of all c-met kinase, and can be used in treatment of oncological diseases. In the compound of the general formula (I) X means hydrogen atom, -OR1, -SR2, -(SO2)R2 or group A1-Q wherein A1 means (C1-C3)-alkylene group; Q means -OR1, -NR3R4, -NHCH2CH2NR3R4; R1 is chosen from group comprising hydrogen atom, (C1-C)-alkyl, dimethylphosphonylmethyl, (R)-2,3-dihydroxy-1-propyl, (S)-2,3-dihydroxy-1-propyl, 1,3-dihydroxy-2-propyl, 3-hydroxy-2-hydroxymethyl-1-propyl, 2-methoxyethoxymethyl, 2,2-dimethyl-1,3-dioxolan-4-ylmethyl or group A1-Q1 wherein Q1 means (C1-C2)-alkoxy, cyano group, carboxyl, (C1-C6)-alkoxycarbonyl, and if A1 means 1,2-ethylene- or 1,3-propylene group then Q1 means hydroxy group; R2 means (C1-C6)-alkyl or A1-Q; R3 and R4 are chosen independently from group comprising hydrogen atom, (C1-C6)-alkyl, or form in common 6-membered saturated cycle comprising two heteroatoms chosen from nitrogen (N) or oxygen (O) atoms; Y means hydrogen atom or group A2-R wherein A2 means (C1-C5)-alkylene optionally substituted with (C1-C6)-alkyl, phenyl or hydroxy group; R means hydroxy group, linear or branched (C1-C6)-alkoxy, amino, dimethylamino, diethylamino, tert.-butyloxycarbonylamino group, carboxyl, (C1-C6)-alkoxycarbonyl, triazolyl, 1-pyrrolidinyl, morpholino group, 4-methylpiperazin-1-yl, O-A1-NR3R4, S-A1-NR3R4, 4-carboxyphenyl, furan-3-yl, thiophen-2-yl or 3-methylthiophen-2-yl; Z means one or two substitutes chosen independently from group comprising halogen atom, hydroxy, allyloxy group, methyl, (C1-C5)-alkoxy, methoxymethoxy, (2-methoxyethocy)methyloxy, methylthio, ethoxymethoxy group, ethynyl and benzyloxy group optionally substituted with halogen atom, methoxy, cyano, ethoxy group, and its pharmaceutically acceptable salts. Also, invention elates to novel intermediate compounds and synthesis of compounds, and to their using for preparing drugs and pharmaceutical composition.
EFFECT: improved method of synthesis, valuable medicinal properties of compounds and pharmaceutical composition.
13 cl, 97 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF THIOPHEN AND PHARMACEUTICAL COMPOSIITON (VERSIONS) | 2003 |
|
RU2359967C2 |
| NEW TRIARYLIMIDAZOLES | 2004 |
|
RU2372346C2 |
| NK1/NK3 DOUBLE AGONISTS FOR TREATING SCHIZOPHRENIA | 2004 |
|
RU2347777C2 |
| PROCESS FOR PRODUCING DERIVATIVES OF 2-IMINOIMIDAZOLIDINE OR THEIR SALTS | 0 |
|
SU910119A3 |
| PROCESS FOR PREPARING DERIVATIVES OF 2-AMINO-1,4,5,6-TETRAHYDROPYRIMIDINE | 0 |
|
SU1063289A3 |
| COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS | 2005 |
|
RU2431635C2 |
| 0 |
|
SU509227A3 | |
| DERIVATIVES OF 2,6-QUINOLINYL AND 2,6-NAPHTHYL, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, THEIR USING AS VLA-4 INHIBITORS AND INTERMEDIATE COMPOUNDS | 2003 |
|
RU2315041C2 |
| 0 |
|
SU539530A3 | |
| PYRIMIDINE-UREA DERIVATIVES AS KINASE INHIBITORS | 2005 |
|
RU2430093C2 |
